Antithrombotic activity of recombinant tick anticoagulant peptide and heparin in a rabbit model of venous thrombosis
- 15 August 1993
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 71 (4) , 317-324
- https://doi.org/10.1016/0049-3848(93)90200-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Thrombectomy, Lysis, or Heparin Treatment: Concurrent Therapies of Deep Vein Thrombosis: Therapy and Experimental StudiesSeminars in Thrombosis and Hemostasis, 1989
- Thrombosis and Virchow's Triad: What Is Established?Seminars in Thrombosis and Hemostasis, 1989
- Overview of Venous ThrombogenesisSeminars in Thrombosis and Hemostasis, 1988
- Heparin inhibits fibrin, but not leukocytes, in a model of deep-vein thrombosisJournal of Surgical Research, 1987
- Prevention of venous thrombosis and pulmonary embolism. NIH Consensus DevelopmentJAMA, 1986
- The effect of heparin fragments of different molecular weights on experimental thrombosis and haemostasisThrombosis Research, 1985
- The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparinBlood, 1985
- Heparin Treatment of Deep Venous Thrombosis in 280 Patients: Symptoms Related to DosageActa Medica Scandinavica, 1984
- Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbitsThrombosis Research, 1982
- Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosisBlood, 1977